Halozyme Therapeutic (HALO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | HALO | CYTK | IBRX | ||
| Company | Halozyme Therapeutic | Cytokinetics | Immunitybio Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 65.27 | 62.44 | 7.25 | ||
| High | 65.28 | 63.60 | 7.27 | ||
| Low | 62.60 | 60.60 | 6.91 | ||
| Latest | 63.86 | 60.69 | 6.96 | ||
| Change | -0.63 | -0.91 | -0.33 | ||
| % Change | -0.98% | -1.48% | -4.53% | ||
| Volume | 1,311,200 | 2,213,100 | 10,876,000 | ||
| 20-Day Average Volume | 1,435,620 | 1,580,250 | 15,046,925 | ||
| Previous Close | 64.49 | 61.60 | 7.29 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 66.32 | 65.34 | 7.48 | ||
| 20-Day Raw Stochastic | 19.75% | 1.11% | 14.89% | ||
| 20-Day Relative Strength | 42.74 | 41.08 | 45.89 | ||
| Weighted Alpha | +1.53 | +26.80 | +3.74 | ||
| Today's Opinion | 80% Sell | 24% Buy | 40% Buy | ||
| Previous Opinion | 80% Sell | 32% Buy | 40% Buy | ||
| Last Month's Opinion | 40% Sell | 8% Buy | 64% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -6.65% since 04/21/26 | -7.77% since 04/21/26 | -14.07% since 04/21/26 | ||
| Low | 62.60 on 04/28/26 | 60.60 on 04/28/26 | 6.91 on 04/28/26 | ||
| High | 70.32 on 04/23/26 | 67.26 on 04/23/26 | 8.38 on 04/22/26 | ||
| 1-Month | |||||
| %Chg | +3.62% since 03/27/26 | -2.90% since 03/27/26 | -5.69% since 03/27/26 | ||
| Low | 61.50 on 03/30/26 | 60.60 on 04/28/26 | 6.57 on 03/30/26 | ||
| High | 70.32 on 04/23/26 | 68.71 on 04/02/26 | 8.56 on 04/21/26 | ||
| 3-Month | |||||
| %Chg | -12.32% since 01/28/26 | -6.83% since 01/28/26 | +13.17% since 01/28/26 | ||
| Low | 61.33 on 03/27/26 | 58.43 on 03/13/26 | 5.58 on 02/05/26 | ||
| High | 82.22 on 02/09/26 | 70.39 on 02/24/26 | 12.43 on 02/25/26 | ||
| 6-Month | |||||
| %Chg | -2.35% since 10/28/25 | -2.07% since 10/28/25 | +169.77% since 10/28/25 | ||
| Low | 61.22 on 12/11/25 | 58.05 on 11/06/25 | 1.95 on 12/31/25 | ||
| High | 82.22 on 02/09/26 | 70.98 on 12/22/25 | 12.43 on 02/25/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 7,640,388 | 7,653,060 | 7,494,929 | ||
| Shares Outstanding, K | 118,474 | 124,238 | 1,028,111 | ||
| Annual Sales | 1,396,610,000 | 88,040,000 | 113,290,000 | ||
| Annual Net Income | 316,890,000 | -784,960,000 | -351,400,000 | ||
| Last Quarter Sales | 451,770,000 | 17,760,000 | 38,290,000 | ||
| Last Quarter Net Income | -141,590,000 | -183,030,000 | -61,940,000 | ||
| 60-Month Beta | 1.03 | 0.47 | 0.13 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.24 on 02/17/26 | -1.50 on 02/24/26 | -0.06 on 02/23/26 | ||
| Earnings Date | 05/05/26 | 05/05/26 | 05/11/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 17.29 | 0.00 | 0.00 | ||